All In Biotech

Drugs by condition

Drugs approved for psoriatic arthritis

Brand-name prescription drugs and biologics whose FDA label lists psoriatic arthritis as an approved use. Matched on the label phrases: "psoriatic arthritis".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

58

Still marketed, NDA or BLA

Drug classes

11

Novel drugs

19

New molecular entities and new biologics

In development

12

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for psoriatic arthritis.

  • Otezla (Apremilast) · Amgen INC OrphanAug 29, 2025
  • Starjemza (Ustekinumab-Hmny) · Bio-Thera Solutions LTD May 22, 2025
  • Otulfi (Ustekinumab-Aauz) · Fresenius Kabi USA Apr 30, 2025
  • Pyzchiva (Ustekinumab-Ttwe) · Samsung Bioepis CO LTD Apr 30, 2025
  • Steqeyma (Ustekinumab-Stba) · Celltrion, Inc. Dec 17, 2024

All approved drugs for psoriatic arthritis, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 151 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Tumor Necrosis Factor Blocker (12)

  • Simponi Golimumab · Centocor Ortho Biotech INC · 2009
  • Cimzia Certolizumab Pegol · Ucb INC · 2008
  • Enbrel Etanercept · Immunex · 1998
  • Remicade Infliximab · Centocor INC · 1998
  • Yusimry Adalimumab-Aqvh · Emerge Bioscience Pte LTD · 2021
  • Avsola Infliximab-Axxq · Amgen INC · 2019
  • Hadlima Adalimumab-Bwwd · Samsung Bioepis CO LTD · 2019
  • Hyrimoz Adalimumab-Adaz · Sandoz INC · 2018
  • Renflexis Infliximab-Abda · Samsung Bioepis CO LTD · 2017
  • Amjevita Adalimumab-Atto · Amgen INC · 2016
  • Inflectra Infliximab-Dyyb · Celltrion INC · 2016
  • Simponi Aria Golimumab · Janssen Biotech · 2013

Interleukin-12 Antagonist (9)

  • Stelara Ustekinumab · Centocor Ortho Biotech INC · 2009
  • Starjemza Ustekinumab-Hmny · Bio-Thera Solutions LTD · 2025
  • Otulfi Ustekinumab-Aauz · Fresenius Kabi USA · 2025
  • Pyzchiva Ustekinumab-Ttwe · Samsung Bioepis CO LTD · 2025
  • Steqeyma Ustekinumab-Stba · Celltrion, Inc. · 2024
  • Pyzchiva Ustekinumab-Ttwe · Samsung Bioepis CO LTD · 2024
  • Wezlana Ustekinumab-Auub · Amgen INC · 2023
  • Wezlana Ustekinumab-Auub · Amgen INC · 2023
  • Stelara Ustekinumab · Janssen Biotech · 2016

Interleukin-23 Antagonist (4)

  • Skyrizi Risankizumab-Rzaa · Abbvie INC · 2019
  • Ilumya Tildrakizumab-Asmn · Sun Pharma Global · 2018
  • Tremfya Guselkumab · Janssen Biotech · 2017
  • Skyrizi Risankizumab-Rzaa · Abbvie INC · 2022

Interleukin-17A Antagonist (3)

  • Taltz Ixekizumab · Eli Lilly and CO · 2016
  • Cosentyx Secukinumab · Novartis Pharms Corp · 2015
  • Cosentyx Secukinumab · Novartis Pharms Corp · 2023

Corticosteroid (3)

  • Medrol Methylprednisolone · Pfizer · 1957
  • Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
  • Cortef Hydrocortisone · Pharmacia and Upjohn · 1952

Janus Kinase Inhibitor (2)

  • Rinvoq Upadacitinib · Abbvie · 2019
  • Rinvoq Lq Upadacitinib · Abbvie · 2024

Phosphodiesterase 4 Inhibitor (2)

  • Otezla Apremilast · Amgen INC · 2014
  • Otezla Apremilast · Amgen INC · 2025

Adrenocorticotropic Hormone (2)

Tyrosine Kinase 2 Inhibitor (1)

  • Sotyktu Deucravacitinib · Bristol · 2022

Selective T Cell Costimulation Modulator (1)

  • Orencia Abatacept · Bristol Myers Squibb · 2005

Class not listed in FDA's data (19)

  • Bimzelx Bimekizumab-Bkzx · Ucb INC · 2023
  • Xeljanz Tofacitinib Citrate · Pf Prism Cv · 2012
  • Humira Adalimumab · Abbvie INC · 2002
  • Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
  • Imuldosa Ustekinumab-Srlf · Accord Biopharma Inc. · 2024
  • Selarsdi Ustekinumab-Aekn · Alvotech USA INC · 2024
  • Simlandi Adalimumab-Ryvk · Alvotech USA INC · 2024
  • Idacio Adalimumab-Aacf · Fresenius Kabi USA · 2024
  • Yuflyma Adalimumab-Aaty · Celltrion · 2023
  • Xeljanz Tofacitinib Citrate · Pfizer · 2020
  • Hulio Adalimumab-Fkjp · Mylan Pharms INC · 2020
  • Abrilada Adalimumab-Afzb · Pfizer INC · 2019
  • Cyltezo Adalimumab-Adbm · Boehringer Ingelheim · 2017
  • Xeljanz Xr Tofacitinib Citrate · Pfizer · 2016
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
  • Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
  • Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
  • Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955

Drugs in development for psoriatic arthritis

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • TQH3906Phase 34 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Psoriasis, Systemic Lupus Erythematosus, Psoriatic Arthritis

  • SHR-1314Phase 33 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Active Non-radiographic Axial Spondyloarthritis, Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis

  • PicankibartPhase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis

  • SHR0302Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Non-segmental Vitiligo, Psoriatic Arthritis

  • TILDPhase 32 trials

    Sun Pharmaceutical Industries Limited · Active Psoriatic Arthritis

  • DDY391Phase 23 trials

    Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease

  • ABBV-701Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis

  • SPY002-072SPY072Phase 22 trials

    Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis

  • ABBV-547Phase 21 trial

    AbbVie · Psoriatic Arthritis

More on psoriatic arthritis: recruiting trials · published research

Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.